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• CASE REPORT •
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Abstract
A 95-year old gentleman developed fatal icteric flare of
chronic hepatitis B despite lamivudine treatment. This article
highlights the atypical presentations of chronic hepatitis B
in elderly patient and the need to consider this possibility
for acute fulminant hepatitis in endemic areas.
Wong WS, Leung WK, Chan HLY. Icteric flare of chronic
hepatitis B in a 95-year old patient. World J Gastroenterol
2003; 9(12): 2876-2877
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CASE REPORT
A 95-year old gentleman was admitted in July 2003 for
decreased appetite and reduced mobility. He enjoyed good past
health and had no history of hepatitis or jaundice. Two weeks
prior to admission, family members noted that he became
drowsier and refused food. He was living at home with family
and had no history of percutaneous exposure before admission.
He had never had tattooing, blood transfusion, casual sex or
illicit drug use. There was no traveling history for more than
twenty years. The patient was not on any medication or herbs.
       On admission, the patient was barely arousable. He could
only answer simple questions. He was in deep jaundice and
dehydrated. There was no stigma of chronic liver disease.
Abdominal examination did not reveal any tenderness,
organomegaly or ascites. Flapping tremor could not be
demonstrated because the patient was in grade 3 hepatic
encephalopathy.
       Blood test results were compatible with the picture of severe
hepatitis. The serum bilirubin level was 188 mmol/l, alkaline
phosphatase was 76 IU/l (normal 40-100 IU/l), and alanine
aminotransferase was 825 IU/l (normal <58 IU/l). The
prothrombin time was prolonged at 18.1 seconds. Platelet count
was 86×109/l. Renal function was normal. Urgent ultrasound
scan showed normal liver echotexture and normal size spleen.
The biliary trees were normal. There was no gallstone.
       His hepatitis B surface antigen (HBsAg) was positive, IgM
anti-hepatitis B core antigen (anti-HBc) was equivocal,
hepatitis B e-antigen was negative, and antibodies to hepatitis
B e-antigen (anti-HBe) was positive. Hepatitis B virus DNA
was 97.9×106 copies/ml by TaqMan real-time polymerase
chain reaction[1]. The serology tests for hepatitis A, C, D and E
viruses were negative.
      Lamivudine 100 mg daily was commenced on the fourth
day of admission, and supportive treatment with vitamin K,
lactulose and intravenous fluids replacement were prescribed.
While the level of alanine aminotransferase was on decreasing
trend, serum bilirubin and prothrombin time gradually
increased (Figure 1). He developed progressive liver failure
with worsening hepatic encephalopathy and eventually
succumbed sixteen days after admission.
Figure 1  Serial blood results of the patient with acute flare of
chronic hepatitis B. The serum bilirubin, alanine aminotrans-
ferase and prothrombin time are shown.
DISCUSSION
This case illustrates an unusual presentation of severe hepatitis
B virus infection at an advanced age. Although liver biopsy
has not been performed, other causes of acute hepatitis have
been excluded by negative drug history and negative serology
tests for other hepatitis viruses. The absence of risky percutaneous
exposure renders the possibility of acute hepatitis B very
unlikely. As a majority of chronic hepatitis B patients are
asymptomatic and most people in Hong Kong do not have
regular health check-up, it is most likely that this patient was
suffering from chronic hepatitis B with HBsAg first discovered
to be positive at this presentation. Equivocal IgM anti-HBc
test is not diagnostic of acute hepatitis B but could also be
detected in severe reactivation of chronic hepatitis B[2].
     According to most prospective series, reactivation of
chronic hepatitis B typically occurred at around the second
and third decades[3-5]. Once a patient develops HBeAg
seroconversion to anti-HBe, the durability reaches eighty
percent. Patients often have quiescent disease afterwards, and
the risks of complications, such as hepatocellular carcinoma
and liver cirrhosis, are considerably reduced. Our patient
probably has achieved sustained HBeAg seroconversion and
disease remission several decades before this admission as he
had negative HBeAg and no sign of liver cirrhosis at the age
of 95. Reactivation of chronic hepatitis B causing jaundice
and liver failure at this advanced age is uncommon. This case
illustrates the importance to consider chronic hepatitis B as a
cause of liver function derangement in endemic areas such
as Asia.
      Icteric reactivation of chronic hepatitis B carries a poor
prognosis even with lamivudine treatment. In a series of 46
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patients with severe reactivation of chronic hepatitis B with
jaundice a quarter of patients died or required liver
transplantation[6]. When both independent predictors of liver-
related mortality including thrombocytopenia (platelet count
below 143×109/l) and hyperbilirubinemia (serum bilirubin
greater than 172 mmol/l) are present, as in our case, the mortality
rate is up to 69.2 %.
      In conclusion, despite atypical presentation and atypical
age group, chronic hepatitis B should be considered in cases
of acute fulminant hepatitis in endemic areas.
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